Koios DS Breast
Breast Cancer Diagnosis
ApprovedCommercial
Key Facts
About Koios Medical
Koios Medical is a private, commercial-stage diagnostics company founded in 2014 and headquartered in Buffalo, New York. The company has developed a proprietary AI/ML software platform, Koios DS™, which provides real-time decision support for radiologists interpreting breast and thyroid ultrasound scans, aiming to improve cancer detection rates and standardize diagnoses. With regulatory clearances in the US and EU, the company is actively deploying its software globally, supported by strategic investment from entities like Mitsui & Co. Koios operates a B2B software-as-a-medical-device (SaMD) business model, generating revenue through its commercial products.
View full company profileTherapeutic Areas
Other Breast Cancer Diagnosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Biopsy/Pathology Module | Ikonopedia | Commercial |
| 4D Mammography | Calidar | Pilot Study |